-
Telemedicine and the ‘foot selfie’ helped providers deliver diabetic foot care during the pandemic
Brian M. Schmidt, DPM, and Laura Shin, DPM, PhD, shared strategies used to maintain access to care and regular physical exams for patients with diabetic foot complications amid COVID-19.
-
Beta cell biology, glucose metabolism will be highlighted in NIDDK Symposium
Emilyn Uy Alejandro, PhD, and Rochelle N. Naylor, MD, will discuss new insight into the heterogeneity of diabetes and how it translates to patient care.
-
Obesity, CVD also of concern in type 1 diabetes
Yehuda Handelsman, MD, Tina Costacou, PhD, and Sophia Zoungas, MBBS (Hons), PhD, FRACP, will examine the dynamics of weight and cardiovascular risk in type 1 diabetes. The symposium includes a debate on drugs to prevent cardiovascular disease.
-
Beyond carb counting: Emerging technology offers new insights into the dynamics of macronutrients and blood glucose
“You could eat a diet of bacon and diet soda all day long and you’d manage your glucose really well. But that wouldn’t be good for your whole health,” said Holly Willis, PhD, RDN, LD.
-
Welcome to the 81st Scientific Sessions
“We have brought together the best and the brightest minds focused on diabetes research and diabetes care,” said ADA CEO Tracey D. Brown.
-
Weighing the costs vs. benefits of SGLT2 inhibitors and GLP-1 receptor agonists
Hui Shao, MD, PhD, will discuss the financial implications these classes of agents, which have transformed diabetes care for individuals who also have cardiovascular disease, have brought to the health care system.
-
Experts will discuss the impact of social justice issues on vulnerable diabetes patient populations
Shivani Agarwal, MD, MPH, Shakira Suglia, ScD, MS, and J. Frank Wharam, MD, MPH, will examine strategies to address risks influenced by social needs and to improve outcomes.
-
Debate to consider value of digital coaching for type 2 diabetes
The digital diabetes care market will be worth upward of $700 million in 2022. Anne L. Peters, MD, and Kasia J. Lipska, MD, MHS, BS, will explore whether it is worth the cost.
-
Despite therapeutic advances, prevention and management of hypoglycemia still susceptible to ‘thinking traps’
Jennifer Sherr, MD, PhD, will highlight new glucagon formulations for treatment, and Nicole de Zoysa, DClinPsych, will review the impact of overcoming psychological obstacles on optimal hypoglycemia management.
-
Experts will examine emerging trends in pancreas transplantation
The average ages of patients who are potentially eligible for pancreas transplantation and of potential organ donors are on the rise, but that is not the only challenge for this sector of the diabetes community, as Eelco J.P. de Koning, MD, PhD, will explain.